# AbbVie Inc. (ABBV) — Q3-2016 Earnings Results

**Report date:** 2016-10-28 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2016

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 6.28%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +0.33% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, indicating a commitment to long-term growth strategies despite not providing specific guidance.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on driving long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise on EPS, which indicates better-than-expected profitability. However, the stock dropped by 6.28% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be cautious about the company's future performance without clearer expectations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2016_